Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Tax Provisions (2016 - 2025)

Haemonetics has reported Tax Provisions over the past 17 years, most recently at $15.2 million for Q4 2025.

  • Quarterly results put Tax Provisions at $15.2 million for Q4 2025, up 22.35% from a year ago — trailing twelve months through Dec 2025 was $51.7 million (up 49.19% YoY), and the annual figure for FY2025 was $44.4 million, up 29.42%.
  • Tax Provisions for Q4 2025 was $15.2 million at Haemonetics, up from $12.6 million in the prior quarter.
  • Over the last five years, Tax Provisions for HAE hit a ceiling of $15.2 million in Q4 2025 and a floor of -$16.4 million in Q2 2021.
  • Median Tax Provisions over the past 5 years was $8.2 million (2022), compared with a mean of $7.4 million.
  • Biggest five-year swings in Tax Provisions: tumbled 477.21% in 2021 and later surged 324.48% in 2025.
  • Haemonetics' Tax Provisions stood at $5.1 million in 2021, then skyrocketed by 82.35% to $9.3 million in 2022, then skyrocketed by 37.51% to $12.8 million in 2023, then fell by 2.85% to $12.4 million in 2024, then increased by 22.35% to $15.2 million in 2025.
  • The last three reported values for Tax Provisions were $15.2 million (Q4 2025), $12.6 million (Q3 2025), and $11.1 million (Q2 2025) per Business Quant data.